Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Daclizumab in Non-Infectious Uveitis
NCT00043667Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Aug 2002
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of daclizumab in intermediate uveitis (IU), posterior uveitis, sponsored by National Eye Institute. Started Aug 2002; status: completed.
02
Drugs
daclizumab
03
Conditions
intermediate uveitis (IU)posterior uveitis
Beyond the preview
Go deeper on NCT00043667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043667.